Prostate cancer update
Authors:
- Brian I. RiniBRBrian I. Rini
- Eric J. SmallESEric J. Small
- 1 May 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 14 (3) , 286-291
Abstract
Recent advances in prostate cancer have focused on treatment strategies in patients with biochemical relapse and novel methods of androgen deprivation therapy such as intermittent therapy, the role of bisphosphonates, and immunotherapeutic approaches. Continued investigation into the mechanism of androgen independence and effective treatments for hormone-refractory disease are described. This article reviews the major advances in prostate cancer published between November 1, 2000, and October 31, 2001.Keywords
This publication has 20 references indexed in Scilit:
- Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinomaCancer, 2001
- PREDICTING RISK OF PROSTATE SPECIFIC ANTIGEN RECURRENCE AFTER RADICAL PROSTATECTOMY WITH THE CENTER FOR PROSTATE DISEASE RESEARCH AND CANCER OF THE PROSTATE STRATEGIC UROLOGIC RESEARCH ENDEAVOR DATABASESJournal of Urology, 2001
- SAFETY AND EFFICACY OF EXISULIND FOR TREATMENT OF RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMYJournal of Urology, 2001
- Chemotherapy in patients with prostate specific antigen-only disease after primary therapy for prostate carcinomaCancer, 2001
- Fatty fish consumption and risk of prostate cancerThe Lancet, 2001
- Prediction of Response to Salvage Radiation Therapy in Patients With Prostate Cancer Recurrence After Radical ProstatectomyJournal of Clinical Oncology, 2001
- Association Between alpha-Tocopherol, gamma-Tocopherol, Selenium, and Subsequent Prostate CancerJNCI: Journal of the National Cancer Institute, 2000
- Natural History of Progression After PSA Elevation Following Radical ProstatectomyJAMA, 1999
- Outcome for Surgically Staged Localized Prostate Cancer Treated With External Beam Radiation TherapyJournal of Urology, 1997
- Intermittent androgen suppression in the treatment of prostate cancer: A preliminary reportUrology, 1995